On March 20, 2024, Flosonics Medical announced it raising of US$20 million in a Series C financing round. This round was led by New Leaf Venture Partners and saw participation from Genesys Capital, iGan Partners and Arboretum Ventures. Flosonics Medical will utilize the funding towards product development and advancement.
Flosonics Medical is a developer of non-invasive devices with an emphasis of wearable sensors, ultrasound and connected devices.
iGan Partners is a venture capital firm that focuses on investing capital and expertise in healthcare companies.
Genesys Capital is a venture capital firm that focuses on investing in companies in the high-growth sectors of life sciences.
New Leaf Venture Partners is a venture capital firm with an emphasis on healthcare technology companies. Osler, Hoskin & Harcourt LLP advised Flosonics Medical with a team consisting of Ryan Unruch, Chad Bayne, Jennifer Humphrey, Bryan Salazar and Daniel Tyberg (Emerging and High Growth Companies). Osler also advised iGan Partners and Genesys Capital with a team consisting of André Perey and Andrew Irwin (Emerging and High Growth Companies).
Key Contacts
Partner, Emerging and High Growth Companies, Toronto
Partner, Emerging and High Growth Companies, Toronto
Team
Partner, Emerging and High Growth Companies, Toronto
Associate, Emerging and High Growth Companies, Toronto
Associate, Emerging and High Growth Companies, Toronto
Associate, Emerging and High Growth Companies, Toronto
Associate, Emerging and High Growth Companies, Toronto